Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | TDP2 | O95551 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | CCNT1 | O60563 | 2/20 | 0.31 |
| ▸ | CDK9 | P50750 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30592714 | 0.81 | TDP2 (0.37) | KMT2AMEN1TDP2LMNAPDK2 | |
| SCHEMBL26626377 | 0.81 | PDK2 (0.35) | KMT2AMEN1TDP2LMNAPDK2 | |
| SCHEMBL29061576 | 0.81 | TDP2 (0.37) | KMT2AMEN1TDP2LMNAPDK2 | |
| SCHEMBL13242789 | 0.78 | CCNT1 (0.33) | NPSR1GAAKMT2AMEN1POLB | |
| SCHEMBL3364776 | 0.75 | GAA (0.47) | NPSR1HTR2AHTR2BGAATDP1 | |
| SCHEMBL204806 | 0.74 | PDK2 (0.44) | HTR2BTDP2PDK2 | |
| SCHEMBL29587737 | 0.74 | PDK2 (0.44) | HTR2BTDP2PDK2 | |
| SCHEMBL29403081 | 0.74 | PDK2 (0.44) | HTR2BTDP2PDK2 | |
| SCHEMBL4423591 | 0.72 | NPSR1 (0.47) | NPSR1HTR2AHTR2BGAAKMT2A | |
| SCHEMBL30592713 | 0.71 | PDK2 (0.37) | HTR2AHTR2BGAAKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8932735-B2 | Aromatic amine derivative and organic electroluminescent element comprising the same | IDEMITSU KOSAN CO., LTD. (JP) | 2015-01-13 | — | — | US | disclosed |
| US-8932735-B2 | Aromatic amine derivative and organic electroluminescent element comprising the same | IDEMITSU KOSAN CO., LTD. (JP) | 2015-01-13 | — | — | US | disclosed |
| US-20120043533-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120043533-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING THE SAME | AOC2, AOC3, H1-4 | NPSR1 1790/4885HTR2A 2221/4885HTR2B 618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.